Prakash Gudsoorkar's Avatar

Prakash Gudsoorkar

@gudnephron.bsky.social

Asso Prof UCCOM I Kidneydoc | @UCKidney Lead, OncoNeph Program โค๏ธ Onconeph, ๐Ÿก dialysis, ICU Neph Deputy Editor @KidneyNews Editorial Board @akdhjounal @BMCNephro โญ๏ธwars ๐Ÿค“ Fav ๐Ÿž๏ธ : Grand Tetons ๐Ÿถ๐Ÿพ๐Ÿฆด Dad ๐Ÿ‡ฎ๐Ÿ‡ณ ~> ๐Ÿ‡จ๐Ÿ‡ฆ ~> ๐Ÿ‡บ๐Ÿ‡ธ

914 Followers  |  621 Following  |  1,164 Posts  |  Joined: 11.11.2024  |  1.685

Latest posts by gudnephron.bsky.social on Bluesky

Post image

This #ASNKidneyNews special section on green nephrology brings together insights from experts advocating responsible innovation in kidney care, balancing clinical efficacy with ecological stewardship. Explore the articles: bit.ly/KN-Green
@gudnephron.bsky.social

09.05.2025 17:20 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

We check renin in all patients refd to the Ottawa hypertension clinic (also 24 hour urine for Na & K)

Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below

02.04.2025 01:17 โ€” ๐Ÿ‘ 19    ๐Ÿ” 4    ๐Ÿ’ฌ 4    ๐Ÿ“Œ 0
Post image

Oral health is often overlooked in nephrology care, despite significant implications. Authors unveil the crosstalk between oral and kidney health. bit.ly/KN1703-18
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews

02.04.2025 13:00 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

What are some of the common and rare indications and complications of therapeutic plasma exchange? Find out in our new study published in BMC Nephrology! ๐Ÿฉธhttps://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-03970-2#citeas

@gudnephron.bsky.social

#NephSky #MedStudentSky

21.02.2025 19:04 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Interplay between periodontitis and chronic kidney disease - Nature Reviews Nephrology Periodontal disease is very common and might represent a non-traditional risk factor for chronic kidney disease (CKD), independently of shared risk factors. Here, the authors discuss the interplay bet...

www.nature.com/articles/s41...

Can someone please share this article's PDF?

12.01.2025 01:44 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
How to improve the environmental impact in hemodialysis: small actions, big changes AbstractBackground and hypothesis. The burden of chronic kidney disease is increasing driven by population aging and the rising of risk factors. In-centre

Interested in Green Nephrology? Brand new paper from ๐Ÿ‡ช๐Ÿ‡ธout in CKJ on how to reduce the environmental footprint of dialysis, a โ€œpower- and water-hungry, and a waste generating interventionโ€
academic.oup.com/ckj/advance-...

22.12.2024 10:35 โ€” ๐Ÿ‘ 8    ๐Ÿ” 4    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

x.com/vincentrk/st...

05.12.2024 16:56 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
CONFIDENCE, FLOW and REGENCY at the HIT session

CONFIDENCE, FLOW and REGENCY at the HIT session

more trials and protocols at the ISNWCN HIT session

more trials and protocols at the ISNWCN HIT session

even the @theisn.org #ISNWCN has two high impact trial sessions!

This has to be one of the #TopNephrology stories

the era of nephrology lagging behind in RCTs is over

#NephSky

04.12.2024 01:43 โ€” ๐Ÿ‘ 19    ๐Ÿ” 7    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

RBC cast - brightfield with SM stain - from patient admitted with AKI, "pneumonia" and fatigue - serologies all negative - biopsy pending ... #UrineMicroscopy #UrinarySediment

29.11.2024 01:32 โ€” ๐Ÿ‘ 15    ๐Ÿ” 6    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Ten Tips in Lupus Nephritis Management Selene T Y Teoh, Desmond Y H Yap, Tak Mao Chan; Ten Tips in Lupus Nephritis Management, Clinical Kidney Journal, , sfae376, https://doi.org/10.1093/ckj/sfa

Ten Tips in Lupus Nephritis Management:
#nephsky
academic.oup.com/ckj/advance-...

24.11.2024 01:25 โ€” ๐Ÿ‘ 6    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
Preview
GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and ...

jamanetwork.com/journals/jam...

GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome

23.11.2024 22:45 โ€” ๐Ÿ‘ 10    ๐Ÿ” 4    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1
Video thumbnail

Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:

18.11.2024 19:15 โ€” ๐Ÿ‘ 27    ๐Ÿ” 13    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1

@asnkidney.bsky.social is here
Journals not yet

18.11.2024 12:57 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

#Nephsky
#Medsky

18.11.2024 04:09 โ€” ๐Ÿ‘ 11    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
AI Curriculum I am still in the โ€œamazed by what AI can doโ€ stage Here is me prompt i am teaching a class on electrolyte abnormalities for nephrologists. What would be good tricky things to teach I thโ€ฆ

I am at the beginning of my AI journey of discovery, you know the place where you are still dumbfounded by what the machine can do. In this case it developed a pretty compelling electrolyte curriculum for nephrology fellows ๐Ÿ˜ณ

pbfluids.com/2024/11/ai-c...

17.11.2024 06:00 โ€” ๐Ÿ‘ 40    ๐Ÿ” 6    ๐Ÿ’ฌ 5    ๐Ÿ“Œ 1
Figures from "Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction"

Figures from "Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction"

FINEARTS-HF trial in JAMA Cardiology:

Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24

https://ja.ma/4euKMwg

17.11.2024 14:55 โ€” ๐Ÿ‘ 11    ๐Ÿ” 8    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Transition from an estimated glomerular filtration rate (eGFR)-based to a risk-based approach to CKD care from KDIGO
#Nephpearls #NephSky

๐Ÿ‘‰ kdigo.org/guidelines/c...

๐Ÿ’ป kidneyfailurerisk.com

17.11.2024 16:38 โ€” ๐Ÿ‘ 14    ๐Ÿ” 5    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

www.kidneynews.org/view/journal...

17.11.2024 14:36 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

www.kidneynews.org/view/journal...

@amyaimei.bsky.social
@asnkidney.bsky.social kidney news

17.11.2024 14:35 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
x.com

x.com/tony_breu/st...

Why iodine is used as IV contrast?
Find this excellent Xorial by @tonybreu.bsky.social
@zacharysmithmd.bsky.social
@drjakenysather.bsky.social
@jayminbpmd.bsky.social

17.11.2024 13:46 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

From X
@ahascience.bsky.social
#AHA24

17.11.2024 03:11 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Aquaporin-1 and Osmosis: From Physiology to Precision in... : Journal of the American Society of Nephrology ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across endothelial cell...

The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...

10.11.2024 15:00 โ€” ๐Ÿ‘ 36    ๐Ÿ” 14    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
Post image

Got my shirt ready for #KidneyWeek

01.10.2022 08:40 โ€” ๐Ÿ‘ 8    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
Video thumbnail

#NPS
Grand Tetons in the backdrop
Bear lake hike

16.11.2024 23:35 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
The Nephrology Nursing Shortage: Insights From a Pandemic - PubMed The Nephrology Nursing Shortage: Insights From a Pandemic

Healthcare staff shortages are on the rise, particularly for
#PD nurses.

๐Ÿ‘‰ **Challenging question:**

Does offering staff-assisted PD help with nurse shortages?

@ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social

Let's think ๐Ÿค” ๐Ÿงต #NephSky

pubmed.ncbi.nlm.nih.gov/34411685/

16.11.2024 09:29 โ€” ๐Ÿ‘ 12    ๐Ÿ” 6    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Prakash Gudsoorkar MD, FASN, FNKF on LinkedIn: Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesityโ€ฆ ๐ŸŒŸ New Hope for Patients with HFpEF and Obesity: Tirzepatide Shows Promising Results ๐ŸŒŸ Exciting findings from a recent international, randomized trialโ€ฆ

www.linkedin.com/posts/prakas...

#AHA24 #CVRM #CVoutcomes #Medsky #Cardiosky #Nephsky

16.11.2024 23:07 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

#Tirzepatide for #HFpEF & Obesity
#SUMMIT Trial

www.nejm.org/doi/full/10....
#NEJM #AHA24 #CardioSky #MedSky
@ahascience.bsky.social @dramitkhera.bsky.social

16.11.2024 21:50 โ€” ๐Ÿ‘ 7    ๐Ÿ” 6    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
GN Chat The Glomerular Center of Northwell now runs a special monthly GN chat to discuss fun and interesting case based discussions of glomerular ...

Follow all our monthly #GN chats at www.nephronpower.com/p/gn-chat.html

16.11.2024 18:08 โ€” ๐Ÿ‘ 9    ๐Ÿ” 6    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 2

#AHA24 #CardioSky #MedSky #Hypertension

15.11.2024 19:45 โ€” ๐Ÿ‘ 4    ๐Ÿ” 3    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 2

#AHA24 @ahascience.bsky.social @ahajournals.bsky.social

Folks attending AHA
-whatโ€™s new in hypertension world?
-whatโ€™s new is heart failure world?

Whom to follow for updates?

16.11.2024 14:57 โ€” ๐Ÿ‘ 6    ๐Ÿ” 2    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

@gudnephron is following 20 prominent accounts